Dyno Therapeutics — named after the high-risk, high reward mountaineering maneuver where an intrepid climber jumps or swings to the next hold, letting go of all contact points — is pioneering an artificial intelligence (AI)-powered approach to gene therapy. Using machine learning and quantitative high-throughput in vivo experimentation, Dyno Therapeutics is inventing new ways to design viral vectors by focusing on cell-targeting capsid proteins from AAVs . . .

Get GEN Edge Today!

See More on the Edge

Continue reading this article and more
with a GEN Edge subscription

Start Your 30-Day Free Trial Now

Log In Join GEN Edge